Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout

HIGHLIGHTS

• who: Zakir Ali from the Quaid-i-Azam University authorization approval number BEC-FBS-QAU2020- Moreover, all the animal studies executed in this research were in accordance with the ARRIVE guidelines. Preparation of ALPu2011loaded NLCs have published the research work: Transdermal delivery of allopurinol-loaded nanostructured lipid carrier in the treatment of gout, in the Journal: (JOURNAL)
• what: This study aimed to fabricate ALP-loaded NLCs followed by their incorporation into HPMC based poloxamer-407 gel. ALP-loaded NLCs gel containing ALP equivalent to 3 mg was used in this study and was compared with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.